XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES

NOTE 1. SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES  

 

Reliance Global Group, Inc., formerly known as Ethos Media Network, Inc. (“RELI”, “Reliance”, or the “Company”) incorporated in Florida on August 2, 2013.

 

Basis of Presentation and Principles of Consolidation

 

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of recurring accruals) necessary for a fair presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, set forth in the Company’s annual report on Form 10-K for the year ended December 31, 2021.

 

The accompanying unaudited condensed consolidated financial statements include the accounts of Reliance Global Group, Inc. and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

 

Liquidity

 

As of June 30, 2022, the Company’s reported cash and restricted cash aggregated balance was approximately $4,397,000, current assets were approximately $6,101,000, while current liabilities were approximately $9,470,000. As of June 30, 2022, the Company had a working capital deficit of approximately $3,369,000 and stockholders’ equity of approximately $21,928,000. For the six months ended June 30, 2022, the Company reported loss from operations of approximately $4,343,000, a non-cash, non-operating gain on the recognition and change in fair value of warrant liabilities of approximately $24,479,000, resulting in an overall net income of approximately $19,836,000. For the six months ended June 30, 2022, the Company reported negative cash flows from operations of approximately $1,311,000. The Company completed a capital offering in January 2022 that raised net proceeds of approximately $17,853,000. Management believes the Company’s financial position and its ability to raise capital to be reasonable and sufficient.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.

 

Cash and Restricted Cash

 

Cash and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated Statements of Cash Flows as follows:

 

   June 30, 2022   June 30, 2021 
Cash  $2,979,769   $6,348,415 
Restricted cash   1,417,635    484,350 
Total cash and restricted cash  $4,397,404   $6,832,765 

 

 

Fair Value of Financial Instruments

 

Level 1 — Observable inputs reflecting quoted prices (unadjusted) in active markets for identical assets and liabilities;

Level 2 — Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability; and

Level 3 — Unobservable inputs for the asset or liability, which include management’s own assumption about the assumptions market participants would use in pricing the asset or liability, including assumptions about risk.

 

Warrant Liabilities: The Company re-measures fair value of its Level 3 warrant liabilities at the balance sheet date, using a binomial option pricing model. The following summarizes the significant unobservable inputs:

 

   June 30, 2022   December 31, 2021 
Stock price  $2.11   $6.44 
Volatility   105%   90%
Time to expiry   4.51    5 
Dividend yield   0%   0%
Risk free rate   3.00%   1.10%

 

The following reconciles fair value of the liability classified warrants:

 

     Series B Warrant Commitment     Series B warrant liabilities     Placement agent warrants   Total 
   Three and Six Months ended June 30, 2022 
   Series B Warrant Commitment   Series B warrant liabilities   Placement agent warrants   Total 
Beginning balance  $37,652,808   $-   $-   $37,652,808 
Initial recognition   -    55,061,119    1,525,923    56,587,042 
Unrealized (gain) loss   17,408,311    (31,980,437)   (946,461)   (15,518,587)
Warrants exercised or transferred   (55,061,119)             (55,061,119)
Ending balance, March 31, 2022  $-   $23,080,682   $579,462   $23,660,144 
Unrealized gain   -    (12,322,737)   (310,514)   (12,633,251)
Ending balance, June 30, 2022   -    10,757,945    268,948    11,026,893 

 

     Series B Warrant Commitment     Total 
   December 31, 2021 
   Series B Warrant Commitment   Total 
Beginning balance  $-   $- 
Initial recognition   20,244,497    20,244,497 
Unrealized gain   17,408,311    17,408,311 
Ending balance  $37,652,808   $37,652,808 

 

Earn-out liabilities: The Company generally values its Level 3 earn-out liabilities using the income valuation approach. Key valuation inputs include contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments. The following table summarizes the significant unobservable inputs used in the fair value measurements:

 

    June 30, 2022     December 31, 2021  
Valuation technique     Discounted cash flow       Discounted cash flow  
Significant unobservable input     Projected revenue and probability of achievement       Projected revenue and probability of achievement  

 

 

The Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework (a special case of the Income Approach). The following summarizes the significant unobservable inputs:

 

   June 30, 2022 
WACC Risk Premium:   14.6%
Volatility   50%
Credit Spread:   11%
Payment Delay (days)   90%
Risk free rate   USD Yield Curve 
Discounting Convention:   Mid-period 
Number of Iterations   100,000 

 

Undiscounted remaining earn out payments are approximately $4,697,644 as of June 30, 2022. The following table reconciles fair value of earn-out liabilities for the period ending June 30, 2022:

 

   June 30, 2022   December 31, 2021 
Beginning balance – January 1  $3,813,878   $2,931,418 
           
Acquisitions and Settlements          
JP Kush Acquisition   -    1,694,166 
Barra Acquisition   600,000    - 
CCS Write-off   -    (81,368)
Altruis partial settlement   (84,473)   (452,236)
Montana final settlement   (326,935)   - 
           
Period adjustments:          
Fair value changes and accretion included in earnings*   354,963    (278,102)
           
Ending balance  $4,357,433   $3,813,878 
Less: Current portion   (3,683,596)   (3,297,855)
Ending balance, less current portion   673,837    516,023 

 

* Recorded as a reduction to general and administrative expenses

 

Revenue Recognition

 

The following table disaggregates the Company’s revenue by line of business, showing commissions earned:

 

Three Months ended June 30, 2022  Medical/Life   Property and Casualty   Total 
Regular            
EBS  $184,851   $-   $184,851 
USBA   12,319    -    12,319 
CCS/UIS   -    57,195    57,195 
Montana   451,705    -    451,705 
Fortman   357,334    205,804    563,138 
Altruis   882,171    -    882,171 
Kush   425,449    -    425,449 
Medigap   1,359,976    -    1,359,976 
Barra   69,925    200,397    270,322 
   $3,743,730   $463,396   $4,207,126 

 

 

Six Months ended June 30, 2022  Medical/Life    Property and Casualty    Total 
Regular               
EBS  $406,035   $-   $406,035 
USBA   25,906    -    25,906 
CCS/UIS   -    101,077    101,077 
Montana   958,426    -    958,426 
Fortman   689,933    403,064    1,092,997 
Altruis   2,187,043    -    2,187,043 
Kush   864,040    -    864,040 
Medigap   2,537,061    -    2,537,061 
Barra   69,925    200,397    270,322 
   $7,738,369   $704,538   $8,442,907 

 

Three Months ended June 30, 2021  Medical/Life   Property and Casualty   Total 
Regular               
EBS   207,201    -    207,201 
USBA   15,395    -    15,395 
CCS/UIS   -    65,348    65,348 
Montana   404,740    -    404,740 
Fortman   276,634    226,337    502,971 
Altruis   729,874    -    729,874 
Kush   265,318    -    265,318 
   $1,899,162   $291,685   $2,190,847 

 

Six Months ended June 30, 2021  Medical/Life   Property and Casualty   Total 
Regular               
EBS  $416,195   $-   $416,195 
USBA   27,620    -    27,620 
CCS/UIS   -    154,166    154,166 
Montana   939,856    -    939,856 
Fortman   526,435    434,109    960,544 
Altruis   1,750,878    -    1,750,878 
Kush   265,318    -    265,318 
                
   $3,926,302   $588,275   $4,514,577 

 

The following, are customers representing 10% or more of total revenue:

SCHEDULE OF CONCENTRATIONS OF REVENUES 

Insurance Carrier  2022   2021 
  

For the three months ended

June 30,

 
Insurance Carrier  2022   2021 
LTC Global   30%   -%
Priority Health   20%   31%
BlueCross BlueShield   -%   28%

 

 

 

Insurance Carrier  2022   2021 
  

For the six months ended

June 30,

 
Insurance Carrier  2022   2021 
BlueCross BlueShield   10%   25%
Priority Health   25%   33%
LTC Global   28%   -%

 

No other single Customer accounted for more than 10% of the Company’s commission revenues. The loss of any significant customer, including Priority Health, BlueCross BlueShield and LTC Global could have a material adverse effect on the Company.

 

Income Taxes

 

The Company recorded no income tax expense for the three and six months ended June 30, 2022 and 2021 because the estimated annual effective tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections of the Company’s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives.

 

As of June 30, 2022 and December 31, 2021, the Company provided a full valuation allowance against its net deferred tax assets since the Company believes it is more likely than not that its deferred tax assets will not be realized.

 

Prior Period Adjustments

 

The Company identified certain immaterial adjustments impacting prior reporting periods. Specifically, the Company identified adjustments to correct certain asset, liability and equity accounts in relation to historical purchase price allocation accounting, historical accrued revenues and true ups of the common stock issuable account.

 

The Company assessed the materiality of the adjustments to prior period financial statements in accordance with Securities and Exchange Commission Staff Accounting Bulletin No. (SAB) 99, Materiality, and SAB 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, and ASC 250, Accounting Changes and Error Corrections.

 

Accordingly, the Company’s comparative condensed consolidated financial statements and impacted notes have been revised from amounts previously reported to reflect these adjustments. The following table illustrates the impact on previously reported amounts and adjusted balances presented in the condensed consolidated financial statements for the period ended June 30, 2022.

SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION 

Account 

12/31/2020

As reported

   Adjustment  

12/31/2020

Adjusted

 
Earn-out liability   2,631,418    300,000    2,931,418 
Goodwill   9,265,070    (503,345)   8,761,725 
Common stock issuable   822,116    (482,116)   340,000 
Additional paid-in-capital   11,377,123    182,116    11,559,239 
Accumulated Deficit   (12,482,281)   122,601    (12,359,680)

 

Account 

3/31/2021

As reported

   Adjustment  

3/31/2021  

Adjusted

 
Common stock issuable   482,116    (482,116)   0 
Additional paid-in-capital   25,810,147    182,116    25,992,263 
Accumulated Deficit   (13,123,609)   150,003    (12,973,606)

 

 

Recently Issued Accounting Pronouncements

 

We do not expect any recently issued accounting pronouncements to have a material effect on our financial statements.